Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 26, 2017 | SVP, GM - Oncology | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,296 | -- | 7,296 | |
| Jul 26, 2017 | SVP/GM, Global Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,739 | -- | 13,739 | |
| Jul 26, 2017 | SVP/GM, Global Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,137 | -- | 13,137 | |
| Jul 26, 2017 | SVP/GM, Global Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,477 | -- | 7,477 | |
| Jul 26, 2017 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,705 | -- | 34,947 | |
| Jul 26, 2017 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,018 | -- | 13,018 | |
| Jul 26, 2017 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,409 | -- | 7,409 | |
| Jul 27, 2017 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 282 | $16.36 | 15,324 | |
| Jul 27, 2017 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,958 | $16.36 | 111,817 | |
| Aug 06, 2017 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 502 | $16.56 | 20,754 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.